✦ LIBER ✦

P-572 A spanish multicentric phase II study of gemcitabine — irinotecan in relapsing or refractory small cell lung cancer (SCLC)

✍ Scribed by Domine, Manuel; Gomez, Ramon Garcia; Provencio, Mariano; Gonzalez Larriba, Jose Luis; Isla, Dolores; Terrasa, Sefa; Andrade, Jesus; Maestu, Inmaculada; Estevez, Laura; Lobo, Francisco

Book ID: 118572267
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 184 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92539-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel and gemcitabine for refractor

Paclitaxel and gemcitabine for refractory or relapsed small cell lung cancer (SCLC). A multicentric phase II study

✍ M. Domine; J. Gonzalez Larriba; R. Garcia Gomez; S. Morales; D. Isla; C. Garcia 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Phase II Trial of Gemcitabine/Irinotecan

Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer

✍ Wolfgang Schuette; Sylke Nagel; Stefan Juergens; Ines Bork; Bettina Wollschlaege 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 508 KB

P-570 Phase II trial of biweekly irinote

P-570 Phase II trial of biweekly irinotecan (CPT-11) plus gemcitabine (GEM) combination in refractory or relapsed Small Cell Lung Cancer (SCLC)

✍ Castellano, Daniel; Ciruelos, Eva; García-Girón, Carlos; Lopez-Martin, Ana; Garr 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Phase II study of weekly irinotecan and

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

✍ Naka, Nobuyuki; Kawahara, Masaaki; Okishio, Kyoichi; Hosoe, Shigeto; Ogawara, Mi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Phase II study of irinotecan and carbopl

Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer

✍ Hirose, Takashi; Horichi, Naoya; Ohmori, Tohru; Ogura, Keiichi; Hosaka, Takamich 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Phase II study of second-line gemcitabin

Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer

✍ Hoang, Tien; Kim, KyungMann; Jaslowski, Anthony; Koch, Paul; Beatty, Peter; McGo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB